Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARECYCLINE vs SATRALIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SARECYCLINE vs SATRALIZUMAB: Safety Overview

Metric SARECYCLINE SATRALIZUMAB
Total FAERS Reports 134 219
Deaths Reported 0 16
Death Rate N/A 7.3%
Hospitalizations 11 108
Average Patient Age 29.1 yrs 51.6 yrs
% Female Patients 53.5% 82.1%
FDA Approval Date Oct 1, 2018 N/A
Manufacturer Almirall, LLC Genentech, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription